Abiopharma

News list

Mahaney Paige 🟡 adjusted position in 13.6K shares of C4 Therapeutics, Inc. (CCCC) at $2.58 Transaction Date: Oct 28, 2025 | Filing ID: 258664

Full text

News bot Oct. 30, 2025, 8:33 p.m.
🔍 Mahaney Paige (Executive)

Company: C4 Therapeutics, Inc. (CCCC)

Report Date: 2025-10-28
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 19,200
- Total shares sold: 5,644
Detailed Transactions and Holdings:
- Acquired 19,200 shares of Common Stock (Direct)
  Date: 2025-10-28 | Code: M | equity_swap_involved: false | shares_owned_after: 105,000.00 | transaction_form_type: 5 | Footnotes: F1
- Sold 5,644 shares of Common Stock at $2.58 per share (Direct)
  Date: 2025-10-28 | Code: F | equity_swap_involved: false | shares_owned_after: 99,356.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on October 28, 2024.
- F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.